πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,435 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8273741

Imidazo-pyridazinyl compounds and uses thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268819

Hexahydrooxazinopterine compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8263121

Solid pharmaceutical preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258252

Sustained-release composition and process for producing the same

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8252814

Agents and crystals for improving excretory potency of urinary bladder

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247429

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247403

Benzoxazepine derivatives and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8246987

Controlled release composition and method of producing the same

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236837

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8222422

Crystal of benzimidazole compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8222411

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8217176

Fused heterocyclic derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8212046

Process for producing crystal

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8202990

Polo-like kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188275

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8183285

Therapeutic agent for irritable bowel syndrome and methods thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8183212

Compound having GPR54 agonistic activity

Takeda Pharmaceutical Company Limited Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8178555

Apoptosis signal-regulating kinase 1 inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8178543

Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8178534

cMET inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173663

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173645

Glucokinase activators

Takeda San Diego, Inc. Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173360

Cell death inhibitor

Takeda Pharmaceutical Company Limited Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173158

Methods of treating gastrointestinal disorders independent of the intake of food

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted